SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Avner Thaler, Moran Artzi, Anat Mirelman, Yael Jacob, Rick C. Helmich, Bart F.L. Nuenen, Tanya Gurevich, Avi Orr-Urtreger, Karen Marder, Susan Bressman, Bastiaan R. Bloem, Talma Hendler, Nir Giladi, Dafna Ben Bashat, A voxel-based morphometry and diffusion tensor imaging analysis of asymptomatic Parkinson's disease-related G2019S LRRK2 mutation carriers, Movement Disorders, 2014, 29, 6
  2. 2
    Sue Lord, Brook Galna, Shirley Coleman, Alison Yarnall, David Burn, Lynn Rochester, Cognition and Gait Show a Selective Pattern of Association Dominated by Phenotype in Incident Parkinson’s Disease, Frontiers in Aging Neuroscience, 2014, 6,

    CrossRef

  3. 3
    Catharina Sjödahl Hammarlund, Maria H. Nilsson, Markus Idvall, Scott R. Rosas, Peter Hagell, Conceptualizing and prioritizing clinical trial outcomes from the perspectives of people with Parkinson’s disease versus health care professionals: a concept mapping study, Quality of Life Research, 2014, 23, 6, 1687

    CrossRef

  4. 4
    Meike Kasten, Eva-Juliane Vollstedt, Christine Klein, Frühsymptome und neuropsychiatrische Symptome bei der Parkinson-Erkrankung, Zeitschrift für Neuropsychologie, 2014, 25, 1, 31

    CrossRef

  5. 5
    Gordon W. Duncan, Tien K. Khoo, Alison J. Yarnall, John T. O'Brien, Shirley Y. Coleman, David J. Brooks, Roger A. Barker, David J. Burn, Health-related quality of life in early Parkinson's disease: The impact of nonmotor symptoms, Movement Disorders, 2014, 29, 2
  6. 6
    Tsuyoshi Suzuki, Tsuyoshi Shiga, Kazue Kuwahara, Sayaka Kobayashi, Shinichi Suzuki, Katsuji Nishimura, Atsushi Suzuki, Yuichiro Minami, Jun Ishigooka, Hiroshi Kasanuki, Nobuhisa Hagiwara, Impact of clustered depression and anxiety on mortality and rehospitalization in patients with heart failure, Journal of Cardiology, 2014,

    CrossRef

  7. 7
    Mayela Rodríguez-Violante, Amin Cervantes-Arriaga, Salvador Velázquez-Osuna, Rodrigo Llorens-Arenas, Humberto Calderón-Fajardo, Dan Piña-Fuentes, Pablo Martinez-Martin, Independent Validation of the SEND-PD and Correlation with the MDS-UPDRS Part IA, Parkinson's Disease, 2014, 2014, 1

    CrossRef

  8. 8
    Alexandru Hanganu, Clotilde Degroot, Oury Monchi, Christophe Bedetti, Béatriz Mejia-Constain, Anne-Louise Lafontaine, Sylvain Chouinard, Marie-Andrée Bruneau, Influence of Depressive Symptoms on Dopaminergic Treatment of Parkinson’s Disease, Frontiers in Neurology, 2014, 5,

    CrossRef

  9. 9
    Sung Reul Kim, Hui Young So, Eunju Choi, Jeong Hee Kang, Hye Young Kim, Sun Ju Chung, Influencing effect of non-motor symptom clusters on quality of life in Parkinson's disease, Journal of the Neurological Sciences, 2014,

    CrossRef

  10. 10
    Elke Kalbe, Annette Petrelli, Leichte kognitive Störungen und Demenz bei Patienten mit Morbus Parkinson, Zeitschrift für Neuropsychologie, 2014, 25, 1, 17

    CrossRef

  11. 11
    Rachel Biemiller, Irene Hegeman Richard, Managing depression in Parkinson’s patients: risk factors and clinical pearls, Neurodegenerative Disease Management, 2014, 4, 4, 329

    CrossRef

  12. 12
    Richard Dodel, Bengt Jönsson, Jens Peter Reese, Yaroslav Winter, Pablo Martinez-Martin, Robert Holloway, Cristina Sampaio, Evžen Růžička, Graeme Hawthorne, Wolfgang Oertel, Werner Poewe, Glenn Stebbins, Oliver Rascol, Christopher G. Goetz, Anette Schrag, Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease, Movement Disorders, 2014, 29, 2
  13. 13
    Masa-aki Higuchi, Yoshio Tsuboi, Tooru Inoue, Kouzou Fukuyama, Hiroshi Abe, Yasuhiko Baba, Tatsuo Yamada, Predictors of the Emergence of Apathy After Bilateral Stimulation of the Subthalamic Nucleus in Patients with Parkinson's Disease, Neuromodulation: Technology at the Neural Interface, 2014, 17, 7
  14. 14
    Lan-Fang Hsu, Ching-Chiu Kao, Mei-Yeh Wang, Chun-Jen Chang, Pei-Shan Tsai, Psychometric testing of a Mandarin Chinese Version of the Clinically Useful Depression Outcome Scale for patients diagnosed with type 2 diabetes mellitus, International Journal of Nursing Studies, 2014, 51, 12, 1595

    CrossRef

  15. 15
    Aleksandra Kudlicka, Linda Clare, John V. Hindle, Quality of life, health status and caregiver burden in Parkinson's disease: relationship to executive functioning, International Journal of Geriatric Psychiatry, 2014, 29, 1
  16. 16
    S. Baillon, M. Dennis, N. Lo, J. Lindesay, Screening for depression in Parkinson's disease: the performance of two screening questions, Age and Ageing, 2014, 43, 2, 200

    CrossRef

  17. 17
    Magda Osman, Agata Ryterska, Kash Karimi, LingLing Tu, Ignacio Obeso, Maarten Speekenbrink, Marjan Jahanshahi, The effects of dopaminergic medication on dynamic decision making in Parkinson's disease, Neuropsychologia, 2014, 53, 157

    CrossRef

  18. 18
    L. Rochester, B. Galna, S. Lord, D. Burn, The nature of dual-task interference during gait in incident Parkinson’s disease, Neuroscience, 2014, 265, 83

    CrossRef

  19. 19
    Connie Marras, Alexander I. Tröster, Jaime Kulisevsky, Glenn T. Stebbins, The tools of the trade: A state of the art “How to Assess Cognition” in the patient with Parkinson's disease, Movement Disorders, 2014, 29, 5
  20. 20
    Sarah Baillon, James Lindesay, Pravin Prabhakaran, Oli Hands, Jonathan Murray, Suzanne Stacey, Sandhya Gaur, Aniruddha Rajkonwar, Jayaraj Padmanabhan, Deepak Shukla, Santanu Chakrabarti, Nelson Lo, Michael Dennis, The utility of the Edinburgh Depression Scale as a screening tool for depression in Parkinson's disease, International Journal of Geriatric Psychiatry, 2014, 29, 12
  21. 21
    Gwyn M. Vernon, Anne E. S. Carty, Christin M. Salemno, Michele M. Siskind, Cathi A. Thomas, Understanding Parkinson disease, The Nurse Practitioner, 2014, 39, 10, 1

    CrossRef

  22. 22
    Sue Lord, Alan Godfrey, Brook Galna, Dadirayi Mhiripiri, David Burn, Lynn Rochester, Ambulatory activity in incident Parkinson’s: more than meets the eye?, Journal of Neurology, 2013, 260, 12, 2964

    CrossRef

  23. 23
    Matej Skorvanek, Iveta Nagyova, Jaroslav Rosenberger, Martina Krokavcova, Radka Ghorbani Saeedian, Johan W. Groothoff, Zuzana Gdovinova, Jitse P. van Dijk, Clinical determinants of primary and secondary fatigue in patients with Parkinson’s disease, Journal of Neurology, 2013, 260, 6, 1554

    CrossRef

  24. 24
    Nancy A. Pachana, Sarah J. Egan, Ken Laidlaw, Nadeeka Dissanayaka, Gerard J. Byrne, Simone Brockman, Rodney Marsh, Sergio Starkstein, Clinical issues in the treatment of anxiety and depression in older adults with Parkinson's disease, Movement Disorders, 2013, 28, 14
  25. 25
    Erin R. Foster, Laura Golden, Ryan P. Duncan, Gammon M. Earhart, Community-Based Argentine Tango Dance Program Is Associated With Increased Activity Participation Among Individuals With Parkinson's Disease, Archives of Physical Medicine and Rehabilitation, 2013, 94, 2, 240

    CrossRef

  26. 26
    T. Lebouvier, J. Delrieu, S. Evain, A. Pallardy, A. Sauvaget, F. Letournel, R. Chevrier, M. Lepetit, M. Vercelletto, C. Boutoleau-Bretonnière, P. Derkinderen, Démences : où sont les corps de Lewy ?, Revue Neurologique, 2013, 169, 11, 844

    CrossRef

  27. 27
    U. Spampinato, F. Tison, Depressione e malattia di Parkinson, EMC - Neurologia, 2013, 13, 1, 1

    CrossRef

  28. 28
    Daniela Di Giuda, Giovanni Camardese, Fabrizio Cocciolillo, Alfonso Fasano, Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT study: reply to comment by Erro et al., European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40, 4, 638

    CrossRef

  29. 29
    S. Rios Romenets, L. Creti, C. Fichten, S. Bailes, E. Libman, A. Pelletier, R.B. Postuma, Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease – A randomized study, Parkinsonism & Related Disorders, 2013, 19, 7, 670

    CrossRef

  30. 30
    Ingrid HWM Sturkenboom, Maud J Graff, George F Borm, Eddy MM Adang, Maria WG Nijhuis-van der Sanden, Bastiaan R Bloem, Marten Munneke, Effectiveness of occupational therapy in Parkinson’s disease: study protocol for a randomized controlled trial, Trials, 2013, 14, 1, 34

    CrossRef

  31. 31
    S. Lord, B. Galna, J. Verghese, S. Coleman, D. Burn, L. Rochester, Independent Domains of Gait in Older Adults and Associated Motor and Nonmotor Attributes: Validation of a Factor Analysis Approach, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2013, 68, 7, 820

    CrossRef

  32. 32
    N. H. Rod, Y. Bordelon, A. Thompson, E. Marcotte, B. Ritz, Major life events and development of major depression in Parkinson's disease patients, European Journal of Neurology, 2013, 20, 4
  33. 33
    R. Ceravolo, D. Frosini, M. Poletti, L. Kiferle, C. Pagni, S. Mazzucchi, D. Volterrani, U. Bonuccelli, Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction, European Journal of Neurology, 2013, 20, 3
  34. 34
    Sue Lord, Brook Galna, Shirley Coleman, David Burn, Lynn Rochester, Mild depressive symptoms are associated with gait impairment in early Parkinson's disease, Movement Disorders, 2013, 28, 5
  35. 35
    Avner Thaler, Anat Mirelman, Rick C. Helmich, Bart F.L. van Nuenen, Keren Rosenberg-Katz, Tanya Gurevich, Avi Orr-Urtreger, Karen Marder, Susan Bressman, Bastiaan R. Bloem, Nir Giladi, Talma Hendler, Neural correlates of executive functions in healthy G2019S LRRK2 mutation carriers, Cortex, 2013, 49, 9, 2501

    CrossRef

  36. 36
    Victor W. Sung, Anthony P. Nicholas, Nonmotor Symptoms in Parkinson's Disease, Neurologic Clinics, 2013, 31, 3, S1

    CrossRef

  37. 37
    Uwe Walter, Sabine Kleinschmidt, Florian Rimmele, Christian Wunderlich, Irene Gemende, Reiner Benecke, Knut Busse, Potential impact of self-perceived prodromal symptoms on the early diagnosis of Parkinson’s disease, Journal of Neurology, 2013, 260, 12, 3077

    CrossRef

  38. 38
    ROSA QUELHAS, Psychiatric Care in Parkinson’s Disease, Journal of Psychiatric Practice, 2013, 19, 2, 118

    CrossRef

  39. 39
    C.H. Schenck, J.Y. Montplaisir, B. Frauscher, B. Hogl, J.-F. Gagnon, R. Postuma, K. Sonka, P. Jennum, M. Partinen, I. Arnulf, V. Cochen de Cock, Y. Dauvilliers, P.-H. Luppi, A. Heidbreder, G. Mayer, F. Sixel-Döring, C. Trenkwalder, M. Unger, P. Young, Y.K. Wing, L. Ferini-Strambi, R. Ferri, G. Plazzi, M. Zucconi, Y. Inoue, A. Iranzo, J. Santamaria, C. Bassetti, J.C. Möller, B.F. Boeve, Y.Y. Lai, M. Pavlova, C. Saper, P. Schmidt, J.M. Siegel, C. Singer, E. St Louis, A. Videnovic, W. Oertel, Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group, Sleep Medicine, 2013, 14, 8, 795

    CrossRef

  40. 40
    Maximilian Pilhatsch, Nils B. Kroemer, Christine Schneider, Georg Ebersbach, Wolfgang H. Jost, Gerd Fuchs, Per Odin, Gerd Reifschneider, Michael Bauer, Heinz Reichmann, Alexander Storch, Reduced Body Mass Index in Parkinson’s Disease, The Journal of Nervous and Mental Disease, 2013, 201, 1, 76

    CrossRef

  41. 41
    D. Weintraub, J. E. Duda, K. Carlson, P. Luo, O. Sagher, M. Stern, K. A. Follett, D. Reda, F. M. Weaver, Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson's disease: results from a randomised, controlled trial, Journal of Neurology, Neurosurgery & Psychiatry, 2013, 84, 10, 1113

    CrossRef

  42. 42
    Michèle Kiesmann, Jean-Baptiste Chanson, Julien Godet, Thomas Vogel, Laetitia Schweiger, Saïd Chayer, Georges Kaltenbach, The Movement Disorders Society criteria for the diagnosis of Parkinson’s disease dementia: their usefulness and limitations in elderly patients, Journal of Neurology, 2013, 260, 10, 2569

    CrossRef

  43. 43
    Valerie Voon, Nicholas Araki Howell, Paul Krack, Brain Stimulation, 2013,

    CrossRef

  44. 44
    Pablo Martinez-Martin, Belen Frades-Payo, Luis Agüera-Ortiz, Angel Ayuga-Martinez, A short Scale for Evaluation of Neuropsychiatric Disorders in Parkinson’s Disease: first psychometric approach, Journal of Neurology, 2012, 259, 11, 2299

    CrossRef

  45. 45
    A.F.G. Leentjens, K. Dujardin, L. Marsh, P. Martinez-Martin, I.H. Richard, S.E. Starkstein, Anxiety and motor fluctuations in Parkinson's disease: A cross-sectional observational study, Parkinsonism & Related Disorders, 2012, 18, 10, 1084

    CrossRef

  46. 46
    Avner Thaler, Jennie Posen, Nir Giladi, Yael Manor, Connie Mayanz, Anat Mirelman, Tanya Gurevich, Appreciation of humor is decreased among patients with Parkinson’s disease, Parkinsonism & Related Disorders, 2012, 18, 2, 144

    CrossRef

  47. 47
    A. M. Strutt, R. Simpson, J. Jankovic, M. K. York, Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson’s disease, European Journal of Neurology, 2012, 19, 1
  48. 48
    U. Spampinato, F. Tison, Dépression et maladie de Parkinson, EMC - Neurologie, 2012, 9, 4, 1

    CrossRef

  49. 49
    Gail K. Auslander, Depressive Symptoms Among Hospitalized Patients in Israel, Social Work in Health Care, 2012, 51, 2, 107

    CrossRef

  50. 50
    Thuy C. Vu, John G. Nutt, Nicholas H. G. Holford, Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease, British Journal of Clinical Pharmacology, 2012, 74, 2
  51. 51
    Barbara S Connolly, Susan H Fox, Drug treatments for the neuropsychiatric complications of Parkinson’s disease, Expert Review of Neurotherapeutics, 2012, 12, 12, 1439

    CrossRef

  52. 52
    Juho Joutsa, Kirsti Martikainen, Tero Vahlberg, Valtteri Kaasinen, Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease, Parkinsonism & Related Disorders, 2012, 18, 10, 1079

    CrossRef

  53. 53
    Juho Joutsa, Kirsti Martikainen, Tero Vahlberg, Valerie Voon, Valtteri Kaasinen, Impulse control disorders and depression in Finnish patients with Parkinson's disease, Parkinsonism & Related Disorders, 2012, 18, 2, 155

    CrossRef

  54. 54
    Oury Monchi, Clotilde Degroot, Beatriz Mejia-Constain, Marie-Andrée Bruneau, Neuroimaging studies of different cognitive profiles in Parkinson's disease, Parkinsonism & Related Disorders, 2012, 18, S77

    CrossRef

  55. 55
    Angela EP Bouwmans, Wim EJ Weber, Neurologists’ diagnostic accuracy of depression and cognitive problems in patients with parkinsonism, BMC Neurology, 2012, 12, 1, 37

    CrossRef

  56. 56
    Iracema Leroi, Hiranmayi Pantula, Kathryn McDonald, Vijay Harbishettar, Neuropsychiatric Symptoms in Parkinson's Disease with Mild Cognitive Impairment and Dementia, Parkinson's Disease, 2012, 2012, 1

    CrossRef

  57. 57
    Anette Schrag, Albert F. Leentjens, Parkinson disease: Scales to detect depression in Parkinson disease, Nature Reviews Neurology, 2012, 8, 7, 359

    CrossRef

  58. 58
    Santiago Perez-Lloret, Olivier Rascol, Parkinson disease: Serotonin reuptake inhibitors for depression in PD, Nature Reviews Neurology, 2012, 8, 7, 365

    CrossRef

  59. 59
    Mayela Rodríguez-Violante, Amin Cervantes-Arriaga, Cecilia Berlanga-Flores, Angel Ruiz-Chow, Prevalence and determinants of depression in Mexican patients with Parkinson's disease, Clinical Neurology and Neurosurgery, 2012, 114, 10, 1293

    CrossRef

  60. 60
    David A. Gallagher, Anette Schrag, Psychosis, apathy, depression and anxiety in Parkinson's disease, Neurobiology of Disease, 2012, 46, 3, 581

    CrossRef

  61. 61
    Alessandro Tessitore, Marianna Amboni, Fabrizio Esposito, Antonio Russo, Marina Picillo, Laura Marcuccio, Maria Teresa Pellecchia, Carmine Vitale, Mario Cirillo, Gioacchino Tedeschi, Paolo Barone, Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait, Parkinsonism & Related Disorders, 2012, 18, 6, 781

    CrossRef

  62. 62
    Genko Oyama, Ramon L. Rodriguez, Jacob D. Jones, Camille Swartz, Stacy Merritt, Richard Unger, Monica Hubmann, Alain Delgado, Ely Simon, Glen M. Doniger, Dawn Bowers, Kelly D. Foote, Hubert H. Fernandez, Michael S. Okun, Selection of Deep Brain Stimulation Candidates in Private Neurology Practices: Referral May Be Simpler than a Computerized Triage System, Neuromodulation: Technology at the Neural Interface, 2012, 15, 3
  63. 63
    Samrat Roychowdhury, Duncan R. Forsyth, Sleep disturbance in Parkinson disease, Journal of Clinical Gerontology and Geriatrics, 2012, 3, 2, 53

    CrossRef

  64. 64
    H. Y. Lou, J. F. Kong, The effects of prenatal maternal depressive symptoms on pain scores in the early postpartum period, Journal of Obstetrics & Gynaecology, 2012, 32, 8, 764

    CrossRef

  65. 65
    Brook Galna, Sue Lord, Daniyal Daud, Neil Archibald, David Burn, Lynn Rochester, Visual sampling during walking in people with Parkinson’s disease and the influence of environment and dual-task, Brain Research, 2012, 1473, 35

    CrossRef

  66. 66
    Shinya Fujiwara, Fumiharu Kimura, Takafumi Hosokawa, Shimon Ishida, Masakazu Sugino, Toshiaki Hanafusa, Anhedonia in Japanese patients with Parkinson's disease, Geriatrics & Gerontology International, 2011, 11, 3
  67. 67
    Albert F.G. Leentjens, Kathy Dujardin, Laura Marsh, Irene H. Richard, Sergio E. Starkstein, Pablo Martinez-Martin, Anxiety rating scales in Parkinson's disease: A validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale, Movement Disorders, 2011, 26, 3
  68. 68
    Anette Schrag, Apathy and depression scales in Parkinson's disease: Are they good enough?, Journal of the Neurological Sciences, 2011, 310, 1-2, 216

    CrossRef

  69. 69
    Lindsey Kirsch-Darrow, Michael Marsiske, Michael S. Okun, Russell Bauer, Dawn Bowers, Apathy and Depression: Separate Factors in Parkinson's Disease, Journal of the International Neuropsychological Society, 2011, 17, 06, 1058

    CrossRef

  70. 70
    Dag Aarsland, Uwe Ehrt, Irena Rektorova, Cognitive and psychiatric disturbances in Parkinson’s disease, Aging Health, 2011, 7, 1, 123

    CrossRef

  71. 71
    Dag Aarsland, Sven Påhlhagen, Clive G. Ballard, Uwe Ehrt, Per Svenningsson, Depression in Parkinson disease—epidemiology, mechanisms and management, Nature Reviews Neurology, 2011, 8, 1, 35

    CrossRef

  72. 72
    Alexander W. Thompson, Honghu Liu, Ron D. Hays, Wayne J. Katon, Rebecca Rausch, Natalie Diaz, Erin L. Jacob, Stefanie D. Vassar, Barbara G. Vickrey, Diagnostic accuracy and agreement across three depression assessment measures for Parkinson’s disease, Parkinsonism & Related Disorders, 2011, 17, 1, 40

    CrossRef

  73. 73
    Sergio Starkstein, Milan Dragovic, Ricardo Jorge, Simone Brockman, Marcelo Merello, Robert G. Robinson, David Bruce, Mark Wilson, Diagnostic criteria for depression in Parkinson's disease: A study of symptom patterns using latent class analysis, Movement Disorders, 2011, 26, 12
  74. 74
    Teresa Paiva, Paulo Bugalho, Carla Bentes, Dreaming and cognition in patients with frontotemporal dysfunction, Consciousness and Cognition, 2011, 20, 4, 1027

    CrossRef

  75. 75
    Y. J. Zhao, L. C. S. Tan, S. C. Li, W. L. Au, S. H. Seah, P. N. Lau, N. Luo, H. L. Wee, Economic burden of Parkinson’s disease in Singapore, European Journal of Neurology, 2011, 18, 3
  76. 76
    Anna Kierzynka, Radosław Kaźmierski, Wojciech Kozubski, Educational level and cognitive impairment in patients with Parkinson disease, Neurologia i Neurochirurgia Polska, 2011, 45, 1, 24

    CrossRef

  77. You have free access to this content77
    K. E. Cruise, R. S. Bucks, A. M. Loftus, R. U. Newton, R. Pegoraro, M. G. Thomas, Exercise and Parkinson’s: benefits for cognition and quality of life, Acta Neurologica Scandinavica, 2011, 123, 1
  78. 78
    Judith Anzures-Cabrera, Ameet Sarpatwari, Julian PT Higgins, Expressing findings from meta-analyses of continuous outcomes in terms of risks, Statistics in Medicine, 2011, 30, 25
  79. 79
    Pablo Martinez-Martin, Martine Jeukens-Visser, Kelly E. Lyons, C. Rodriguez-Blazquez, Caroline Selai, Andrew Siderowf, Mickie Welsh, Werner Poewe, Oliver Rascol, Cristina Sampaio, Glenn T. Stebbins, Christopher G. Goetz, Anette Schrag, Health-related quality-of-life scales in Parkinson's disease: Critique and recommendations, Movement Disorders, 2011, 26, 13
  80. 80
    Regina Margis, Rogério Margis, Carlos R.M. Rieder, Identification of blood microRNAs associated to Parkinsońs disease, Journal of Biotechnology, 2011, 152, 3, 96

    CrossRef

  81. 81
    Jung Woo Cho, Jong Sam Baik, Myung Sik Lee, Mesencephalic midline change on transcranial sonography in early Parkinson's disease patients with depression, Journal of the Neurological Sciences, 2011, 310, 1-2, 50

    CrossRef

  82. 82
    Julius Huebl, Thomas Schoenecker, Sandy Siegert, Christof Brücke, Gerd-Helge Schneider, Andreas Kupsch, Kielan Yarrow, Andrea A. Kühn, Modulation of subthalamic alpha activity to emotional stimuli correlates with depressive symptoms in Parkinson's disease, Movement Disorders, 2011, 26, 3
  83. 83
    Daniel Weintraub, David J. Burn, Parkinson's disease: The quintessential neuropsychiatric disorder, Movement Disorders, 2011, 26, 6
  84. 84
    Take C. van der Hoek, Boudewijn A.A. Bus, Patricia Matui, Marjolein A. van der Marck, Rianne A. Esselink, Indira Tendolkar, Prevalence of depression in Parkinson's disease: Effects of disease stage, motor subtype and gender, Journal of the Neurological Sciences, 2011, 310, 1-2, 220

    CrossRef

  85. 85
    Pasquale Montagna, Magdolna Hornyak, Jan Ulfberg, Seung Bong Hong, Juergen Koester, Giovanna Crespi, Stefan Albrecht, Randomized trial of pramipexole for patients with restless legs syndrome (RLS) and RLS-related impairment of mood, Sleep Medicine, 2011, 12, 1, 34

    CrossRef

  86. 86
    Sonny K.H. Tan, Henrike Hartung, Trevor Sharp, Yasin Temel, Serotonin-dependent depression in Parkinson’s disease: A role for the subthalamic nucleus?, Neuropharmacology, 2011, 61, 3, 387

    CrossRef

  87. 87
    Albert F. G. Leentjens, Kathy Dujardin, Laura Marsh, Pablo Martinez-Martin, Irene H. Richard, Sergio E. Starkstein, Symptomatology and markers of anxiety disorders in Parkinson's disease: A cross-sectional study, Movement Disorders, 2011, 26, 3
  88. 88
    Eva Havlikova, Jitse P. van Dijk, Iveta Nagyova, Jaroslav Rosenberger, Berrie Middel, Tatiana Dubayova, Zuzana Gdovinova, Johan W. Groothoff, The impact of sleep and mood disorders on quality of life in Parkinson’s disease patients, Journal of Neurology, 2011, 258, 12, 2222

    CrossRef

  89. 89
    K. Imamura, N. Okayasu, T. Nagatsu, The relationship between depression and regional cerebral blood flow in Parkinson’s disease and the effect of selegiline treatment, Acta Neurologica Scandinavica, 2011, 124, 1
  90. 90
    Andreas Charidimou, John Seamons, Caroline Selai, Anette Schrag, The Role of Cognitive-Behavioural Therapy for Patients with Depression in Parkinson's Disease, Parkinson's Disease, 2011, 2011, 1

    CrossRef

  91. 91
    Albert F.G. Leentjens, The Role of Dopamine Agonists in the Treatment of Depression in Patients with Parkinsonʼs Disease, Drugs, 2011, 71, 3, 273

    CrossRef

  92. 92
    Alexander Storch, Yvonne Paelecke-Habermann, Christine B. Schneider, Wolfgang H. Jost, Gerd Fuchs, Per Odin, Gerd Reifschneider, Michael Bauer, Heinz Reichmann, Bernd Leplow, Georg Ebersbach, Validity of the DESPAR questionnaire as a new screening tool for depression in Parkinson’s disease, Basal Ganglia, 2011, 1, 2, 97

    CrossRef

  93. 93
    Angelo Antonini, Pablo Martinez-Martin, Ray K. Chaudhuri, Marcelo Merello, Robert Hauser, Regina Katzenschlager, Per Odin, Mark Stacy, Fabrizio Stocchi, Werner Poewe, Oliver Rascol, Cristina Sampaio, Anette Schrag, Glenn T. Stebbins, Christopher G. Goetz, Wearing-off scales in Parkinson's disease: Critique and recommendations, Movement Disorders, 2011, 26, 12
  94. 94
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  95. 95
    G. Fénelon, La maladie de Parkinson, 2011,

    CrossRef

  96. 96
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  97. 97
    Laurence Nègre-Pagès, Hélène Grandjean, Maryse Lapeyre-Mestre, Jean Louis Montastruc, Annie Fourrier, Jean Pierre Lépine, Oliver Rascol, Anxious and depressive symptoms in Parkinson's disease: The French cross-sectionnal DoPaMiP study, Movement Disorders, 2010, 25, 2
  98. 98
    Kenn Freddy Pedersen, Guido Alves, Kolbjørn Brønnick, Dag Aarsland, Ole-Bjørn Tysnes, Jan Petter Larsen, Apathy in drug-naïve patients with incident Parkinson’s disease: the Norwegian ParkWest study, Journal of Neurology, 2010, 257, 2, 217

    CrossRef

  99. 99
    Jennifer S.A.M. Reijnders, Richel Lousberg, Albert F.G. Leentjens, Assessment of depression in Parkinson's disease: The contribution of somatic symptoms to the clinimetric performance of the Hamilton and Montgomery–Åsberg rating scales, Journal of Psychosomatic Research, 2010, 68, 6, 561

    CrossRef

  100. 100
    Trevor Archer, Richard M. Kostrzewa, Tomas Palomo, Richard J. Beninger, Clinical Staging in the Pathophysiology of Psychotic and Affective Disorders: Facilitation of Prognosis and Treatment, Neurotoxicity Research, 2010, 18, 3-4, 211

    CrossRef

  101. 101
    Carlos Zubaran, Katia Foresti, Mariana Rossi Thorell, Paulo Franceschini, Wagner Homero, Depressive Symptoms in Crack and Inhalant Users in Southern Brazil, Journal of Ethnicity in Substance Abuse, 2010, 9, 3, 221

    CrossRef

  102. 102
    Henri Cohen, Marie-Hélène Gagné, Ursula Hess, Emmanuelle Pourcher, Emotion and object processing in Parkinson’s disease, Brain and Cognition, 2010, 72, 3, 457

    CrossRef

  103. 103
    V. Voon, C. Brezing, C. Gallea, R. Ameli, K. Roelofs, W. C. LaFrance, M. Hallett, Emotional stimuli and motor conversion disorder, Brain, 2010, 133, 5, 1526

    CrossRef

  104. 104
    Joseph H. Friedman, Guido Alves, Peter Hagell, Johan Marinus, Laura Marsh, Pablo Martinez-Martin, Christopher G. Goetz, Werner Poewe, Olivier Rascol, Cristina Sampaio, Glenn Stebbins, Anette Schrag, Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease, Movement Disorders, 2010, 25, 7
  105. 105
    Miguel Coelho, Maria J. Marti, Eduardo Tolosa, Joaquim J. Ferreira, Francesc Valldeoriola, Mário Rosa, Cristina Sampaio, Late-stage Parkinson’s disease: the Barcelona and Lisbon cohort, Journal of Neurology, 2010, 257, 9, 1524

    CrossRef

  106. 106
    C.G. Goetz, Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) : une nouvelle échelle pour l’évaluation de la maladie de Parkinson, Revue Neurologique, 2010, 166, 1, 1

    CrossRef

  107. 107
    Christopher G. Goetz, New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease, Movement Disorders, 2010, 25, S1
  108. 108
    Pablo Martínez-Martín, Javier Damián, Parkinson disease: Depression and anxiety in Parkinson disease, Nature Reviews Neurology, 2010, 6, 5, 243

    CrossRef

  109. 109
    Hubert H Fernandez, Marcelo Merello, Pramipexole for depression and motor symptoms in Parkinson's disease: can we kill two birds with one stone?, The Lancet Neurology, 2010, 9, 6, 556

    CrossRef

  110. 110
    Paolo Barone, Werner Poewe, Stefan Albrecht, Catherine Debieuvre, Dan Massey, Olivier Rascol, Eduardo Tolosa, Daniel Weintraub, Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial, The Lancet Neurology, 2010, 9, 6, 573

    CrossRef

  111. 111
    Birgit Högl, Isabelle Arnulf, Cynthia Comella, Joaquim Ferreira, Alex Iranzo, Barbara Tilley, Claudia Trenkwalder, Werner Poewe, Olivier Rascol, Cristina Sampaio, Glenn T. Stebbins, Anette Schrag, Christopher G. Goetz, Scales to assess sleep impairment in Parkinson's disease: Critique and recommendations, Movement Disorders, 2010, 25, 16
  112. 112
    Carlo Colosimo, Pablo Martínez-Martín, Giovanni Fabbrini, Robert A. Hauser, Marcelo Merello, Janis Miyasaki, Werner Poewe, Cristina Sampaio, Olivier Rascol, Glenn T. Stebbins, Anette Schrag, Christopher G. Goetz, Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations, Movement Disorders, 2010, 25, 9
  113. 113
    Alessandra Nicoletti, Pierfrancesco Pugliese, Giuseppe Nicoletti, Gennarina Arabia, Grazia Annesi, Michele De Mari, Paolo Lamberti, Simone Gallerini, Roberto Marconi, Antonio Epifanio, Letterio Morgante, Autilia Cozzolino, Paolo Barone, Giuseppina Torchia, Aldo Quattrone, Mario Zappia, The FRAGAMP study: environmental and genetic factors in Parkinson’s disease, methods and clinical features, Neurological Sciences, 2010, 31, 1, 47

    CrossRef

  114. 114
    Endre Pal, Ferenc Nagy, Zsuzsanna Aschermann, Eva Balazs, Norbert Kovacs, The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: A randomized, double-blind, placebo-controlled study, Movement Disorders, 2010, 25, 14
  115. 115
    Sara Varanese, Zoe Birnbaum, Roger Rossi, Alessandro Di Rocco, Treatment of Advanced Parkinson's Disease, Parkinson's Disease, 2010, 2010, 1

    CrossRef

  116. 116
    Christine B. Schneider, Maximilian Pilhatsch, Martina Rifati, Wolfgang H. Jost, Franziska Wodarz, Georg Ebersbach, Daniela Djundja, Gerd Fuchs, Arne Gies, Per Odin, Gerd Reifschneider, Martin Wolz, Antonia Bottesi, Michael Bauer, Heinz Reichmann, Alexander Storch, Utility of the WHO-five well-being index as a screening tool for depression in Parkinson's disease, Movement Disorders, 2010, 25, 6
  117. You have free access to this content117
    Jennifer De Souza, Lisa A. Jones, Hugh Rickards, Validation of self-report depression rating scales in Huntington's disease, Movement Disorders, 2010, 25, 1
  118. 118
    Marcos Hortes Nisihara Chagas, Vitor Tumas, Sonia Regina Loureiro, Jaime E.C. Hallak, Clarissa Trzesniak, João Paulo Machado de Sousa, Guilherme Gustavo Ricciopo Rodrigues, Alaor Santos Filho, José Alexandre S. Crippa, Validity of a Brazilian version of the Zung self-rating depression scale for screening of depression in patients with Parkinson's disease, Parkinsonism & Related Disorders, 2010, 16, 1, 42

    CrossRef

  119. 119
    L. Marsh, Encyclopedia of Movement Disorders, 2010,

    CrossRef

  120. 120
    J.G. Goldman, B.A. Bernard, Encyclopedia of Movement Disorders, 2010,

    CrossRef

  121. 121
    Juan Carlos Gómez-Esteban, Beatriz Tijero, Johanne Somme, Iker Bilbao, Julen Fernández, Sabas Boyero, Fernando Velasco, Elena Lezcano, J.J. Zarranz, Application of depression criteria (DSM-IV) in patients with Parkinson's disease, Clinical Neurology and Neurosurgery, 2009, 111, 8, 665

    CrossRef

  122. 122
    Luc Defebvre, Dépression dans la maladie de Parkinson, La Presse Médicale, 2009, 38, 6, 869

    CrossRef

  123. 123
    Jin Zheng, Shenggang Sun, Xian Qiao, Yudong Liu, Depression in patients with Parkinson’s disease and the associated features, Journal of Huazhong University of Science and Technology [Medical Sciences], 2009, 29, 6, 725

    CrossRef

  124. 124
    Swen Hesse, Philipp M. Meyer, Karl Strecker, Henryk Barthel, Florian Wegner, Christian Oehlwein, Ioannis Ugo Isaias, Johannes Schwarz, Osama Sabri, Monoamine transporter availability in Parkinson’s disease patients with or without depression, European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36, 3, 428

    CrossRef

  125. 125
    Dag Aarsland, Laura Marsh, Anette Schrag, Neuropsychiatric symptoms in Parkinson's disease, Movement Disorders, 2009, 24, 15
  126. 126
    Heinz Reichmann, Christine Schneider, Matthias Löhle, Non-motor features of Parkinson's disease: depression and dementia, Parkinsonism & Related Disorders, 2009, 15, S87

    CrossRef

  127. 127
    Amy H. Farabaugh, Joseph J. Locascio, Liang Yap, Daniel Weintraub, William M. McDonald, Monica Agoston, Jonathan E. Alpert, John Growdon, Maurizio Fava, Pattern of Depressive Symptoms in Parkinson's Disease, Psychosomatics, 2009, 50, 5, 448

    CrossRef

  128. 128
    Kenn Freddy Pedersen, Jan Petter Larsen, Guido Alves, Dag Aarsland, Prevalence and clinical correlates of apathy in Parkinson's disease: A community-based study, Parkinsonism & Related Disorders, 2009, 15, 4, 295

    CrossRef

  129. 129
    Carmen Rodriguez-Blazquez, Belen Frades-Payo, Maria João Forjaz, Jesus de Pedro-Cuesta, Pablo Martinez-Martin, Psychometric attributes of the Hospital Anxiety and Depression Scale in Parkinson's disease, Movement Disorders, 2009, 24, 4
  130. 130
    Regina Margis, Karina Donis, Suzana Veiga Schönwald, Simone Chaves Fagondes, Thais Monte, Pablo Martín-Martínez, K. Ray Chaudhuri, Flávio Kapczinski, Carlos R.M. Rieder, Psychometric properties of the Parkinson's Disease Sleep Scale – Brazilian version, Parkinsonism & Related Disorders, 2009, 15, 7, 495

    CrossRef

  131. 131
    Maria João Forjaz, Carmen Rodriguez-Blázquez, Pablo Martinez-Martin, Rasch analysis of the hospital anxiety and depression scale in Parkinson's disease, Movement Disorders, 2009, 24, 4
  132. 132
    Joo Young Oh, Ye-Sung Kim, Byung Hee Choi, Eun Hee Sohn, Ae Young Lee, Relationship between clinical phenotypes and cognitive impairment in Parkinson's disease (PD), Archives of Gerontology and Geriatrics, 2009, 49, 3, 351

    CrossRef

  133. 133
    Daniel A. Nation, Heather L. Katzen, Spyridon Papapetropoulos, Blake K. Scanlon, Bonnie E. Levin, Subthreshold depression in Parkinson's disease, International Journal of Geriatric Psychiatry, 2009, 24, 9
  134. 134
    Bernard Ravina, Jordan Elm, Richard Camicioli, Peter G. Como, Laura Marsh, Joseph Jankovic, Daniel Weintraub, The course of depressive symptoms in early Parkinson's disease, Movement Disorders, 2009, 24, 9
  135. 135
    Albert F.G. Leentjens, Jürgen Koester, Barbara Fruh, D. Toby S. Shephard, Paolo Barone, John J.G. Houben, The effect of pramipexole on mood and motivational symptoms in parkinson's disease: A meta-analysis of placebo-controlled studies, Clinical Therapeutics, 2009, 31, 1, 89

    CrossRef

  136. 136
    James R. Williams, Laura Marsh, Validity of the Cornell scale for depression in dementia in Parkinson's disease with and without cognitive impairment, Movement Disorders, 2009, 24, 3
  137. 137
    Albert F.G. Leentjens, Kathy Dujardin, Laura Marsh, Pablo Martinez-Martin, Irene H. Richard, Sergio E. Starkstein, Daniel Weintraub, Christina Sampaio, Werner Poewe, Oliver Rascol, Glenn T. Stebbins, Christopher G. Goetz, Anxiety rating scales in Parkinson's disease: Critique and recommendations, Movement Disorders, 2008, 23, 14
  138. 138
    Albert F.G. Leentjens, Kathy Dujardin, Laura Marsh, Pablo Martinez-Martin, Irene H. Richard, Sergio E. Starkstein, Daniel Weintraub, Cristina Sampaio, Werner Poewe, Oliver Rascol, Glenn T. Stebbins, Christopher G. Goetz, Apathy and anhedonia rating scales in Parkinson's disease: Critique and recommendations, Movement Disorders, 2008, 23, 14
  139. 139
    David Devos, Kathy Dujardin, Isabelle Poirot, Caroline Moreau, Olivier Cottencin, Pierre Thomas, Alain Destée, Regis Bordet, Luc Defebvre, Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double-blind, randomized, placebo-controlled study, Movement Disorders, 2008, 23, 6
  140. 140
    Pei-Hao Chen, Shih-Jung Cheng, Depression in Parkinson Disease: Current Understanding and Treatment, International Journal of Gerontology, 2008, 2, 4, 172

    CrossRef

  141. 141
    S. E. Pålhagen, M. Carlsson, E. Curman, J. Wålinder, A.-K. Granérus, Depressive illness in Parkinson’s disease – indication of a more advanced and widespread neurodegenerative process?, Acta Neurologica Scandinavica, 2008, 117, 5
  142. 142
    David A Gallagher, Anette Schrag, Impact of Newer Pharmacological Treatments on Quality of Life in Patients with Parkinson???s Disease, CNS Drugs, 2008, 22, 7, 563

    CrossRef

  143. 143
    J. Kulisevsky, J. Pagonabarraga, B. Pascual-Sedano, A. Gironell, C. García-Sánchez, M. Martínez-Corral, Motor changes during sertraline treatment in depressed patients with Parkinson’s disease, European Journal of Neurology, 2008, 15, 9
  144. You have free access to this content144
    Christopher G. Goetz, Barbara C. Tilley, Stephanie R. Shaftman, Glenn T. Stebbins, Stanley Fahn, Pablo Martinez-Martin, Werner Poewe, Cristina Sampaio, Matthew B. Stern, Richard Dodel, Bruno Dubois, Robert Holloway, Joseph Jankovic, Jaime Kulisevsky, Anthony E. Lang, Andrew Lees, Sue Leurgans, Peter A. LeWitt, David Nyenhuis, C. Warren Olanow, Olivier Rascol, Anette Schrag, Jeanne A. Teresi, Jacobus J. van Hilten, Nancy LaPelle, Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results, Movement Disorders, 2008, 23, 15
  145. 145
    Susan H Fox, Jonathan M Brotchie, Anthony E Lang, Non-dopaminergic treatments in development for Parkinson's disease, The Lancet Neurology, 2008, 7, 10, 927

    CrossRef

  146. 146
    Pablo Martinez-Martin, Martine Visser, Carmen Rodriguez-Blazquez, Johan Marinus, K. Ray Chaudhuri, Jacobus J. van Hilten, SCOPA-sleep and PDSS: Two scales for assessment of sleep disorder in Parkinson's disease, Movement Disorders, 2008, 23, 12
  147. 147
    Sharon Muzerengi, Donatella Contrafatto, K. Ray Chaudhuri, Non-motor symptoms: Identification and management, Parkinsonism & Related Disorders, 2007, 13, S450

    CrossRef

  148. 148
    Christopher G. Goetz, Cristina Sampaio, Assessment of Non-Motor Features of Parkinson's Disease: Scales and Rating Tools,
  149. 149
    Karl Kieburtz, Clinical Trial Measures of the Non-Motor Features of Parkinson's Disease,
  150. 150
    Tiffini Voss, Irene Hegeman Richard, Depression in Parkinson's Disease,
  151. 151
    John V. Hindle, Mood Disorders in Parkinson's Disease,
  152. 152
    Adriana P. Hermida, William M. McDonald, The Assessment of Depressive Syndromes,